In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter Healthcare Corp.

https://www.baxter.com/

Latest From Baxter Healthcare Corp.

China New Government Policies Taking Shape As Two Sessions Underway

Moderate growth goal and lingering impact from COVID policies dampen prospects of a quick recovery for China.

Policy China

FY2022: Medtech Innovators Exchange Top 10 Placings

The leading global medtechs’ fiscal 2022 revenue reports are all in: Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished the year with strong quarters and Roche dropped a few places.

Sales & Earnings Market Intelligence

Global Top 10 Medtechs Swap Places After Latest Quarterlies

Abbott Laboratories moved above Medtronic in MAT medtech revenues, while Philips Healthcare and Stryker finished 2022 with strong quarters, and Roche dropped a few places.

Sales & Earnings Commercial

Medtechs Weigh Up Preferred Growth Strategies As Pandemic Tails Out

Medtech M&A was at a decade low in 2022 and IPOs was a closed market, says EY life sciences partner John Babitt, who gave his thoughts on likely strategic activity in the year ahead to In Vivo.

Market Intelligence M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register